Sirolimus

Generic name: Pronounced as (sir oh' li mus)
Brand names
  • Rapamune®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2016

Sirolimus may increase the risk that you will develop an infection or cancer, especially lymphoma (cancer of a part of the immune system) or skin cancer. To reduce your risk of skin cancer, plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen during your treatment. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, chills, frequent or painful urination, or other signs of infection; new sores or changes on the skin; night sweats; swollen glands in the neck, armpits, or groin; unexplained weight loss; trouble breathing; chest pain; weakness or tiredness that does not go away; or pain, swelling, or fullness in the stomach.

Sirolimus may cause serious side effects or death in patients who have had liver or lung transplants. This medication should not be given to prevent rejection of liver or lung transplants.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests to check your body's response to sirolimus.

Talk to your doctor about the risks of taking sirolimus.

Sirolimus is used in combination with other medications to prevent rejection of kidney transplants. Sirolimus is in a class of medications called immunosuppressants. It works by suppressing the body's immune system.

Sirolimus comes as a tablet and a solution (liquid) to take by mouth. It is usually taken once a day, either always with food or always without food. To help you remember to take sirolimus, take it around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take sirolimus exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the tablets whole; do not split, chew, or crush them.

Your doctor will probably adjust your dose of sirolimus during your treatment, usually not more than once every 7 to 14 days.

Continue to take sirolimus even if you feel well. Do not stop taking sirolimus without talking to your doctor.

Sirolimus solution may develop a haze when refrigerated. If this happens, let the bottle stand at room temperature and gently shake it until the haze goes away. The haze does not mean that the medication is damaged or unsafe to use.

To use the bottles of solution, follow these steps:

  1. Open the solution bottle. On first use, insert the plastic tube with stopper tightly into the bottle until it is even with the top of the bottle. Do not remove from the bottle once inserted.

  2. For each use, tightly insert one of the amber syringes, with the plunger fully pushed in, into the opening in the plastic tube.

  3. Draw up the amount of solution your doctor has prescribed by gently pulling out the plunger of the syringe until the bottom of the black line of the plunger is even with the correct mark on the syringe. Keep the bottle upright. If bubbles form in the syringe, empty the syringe into the bottle and repeat this step.

  4. Empty the syringe into a glass or plastic cup containing at least 2 ounces (60 milliliters [1/4 cup]) of water or orange juice. Do not use apple juice, grapefruit juice, or other liquids. Stir vigorously for 1 minute and drink immediately.

  5. Refill the cup with at least 4 ounces (120 milliliters [1/2 cup]) of water or orange juice. Stir vigorously and drink the rinse solution.

  6. Dispose of the used syringe.

If you need to carry a filled syringe with you, snap a cap onto the syringe and put the syringe in the carrying case. Use the medication in the syringe within 24 hours.

Sirolimus also is used sometimes to treat psoriasis. Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking sirolimus,

  • tell your doctor and pharmacist if you are allergic to sirolimus, any other medications, or any of the ingredients in sirolimus tablets or solution. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking. Be sure to mention any of the following: aminoglycoside antibiotics such as amikacin, gentamicin, kanamycin, neomycin (Neo-Fradin, Neo-Rx), streptomycin, and tobramycin (Tobi); amphotericin B (Abelcet, AmBisome, Amphocin, Fungizone); angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik); antifungals such as clotrimazole (Lotrimin), fluconazole (Diflucan), itraconazole (Sporanox), ketoconazole (Nizoral), and voriconazole (Vfend); bromocriptine (Cycloset, Parlodel); cimetidine (Tagamet); cisapride (Propulsid) (not available in the U.S.); clarithromycin (Biaxin); danazol (Danocrine); diltiazem (Cardizem, Dilacor, Tiazac); erythromycin (E.E.S., E-Mycin, Erythrocin); HIV protease inhibitors such as indinavir (Crixivan) and ritonavir (Norvir, in Kaletra); certain medications for cholesterol; medications for seizures such as carbamazepine (Tegretol), phenobarbital (Luminal), and phenytoin (Dilantin); metoclopramide (Reglan); nicardipine (Cardene); rifabutin (Mycobutin); rifampin (Rifadin, Rimactane); rifapentine (Priftin); telithromycin (Ketek); troleandomycin (TAO) (not available in the U.S.); and verapamil (Calan, Covera, Isoptin, Verelan). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • if you are taking cyclosporine (Neoral) soft gelatin capsules or solution, take them 4 hours before sirolimus.

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • tell your doctor if you have or have ever had high cholesterol or triglycerides or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should use an effective method of birth control before starting to take sirolimus, while taking sirolimus, and for 12 weeks after stopping sirolimus. If you become pregnant while taking sirolimus, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking sirolimus.

  • do not have any vaccinations without talking to your doctor.

Avoid drinking grapefruit juice while taking this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Sirolimus may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • stomach pain

    • headache

    • constipation

    • diarrhea

    • nausea

    • joint pain

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them or those listed in the IMPORTANT WARNING section, call your doctor immediately:

    • unusual bleeding or bruising

    • cough

    • swollen, red, cracked, scaly skin

    • hives

    • rash

    • itching

    • difficulty breathing or swallowing

    • swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs

    • hoarseness

  • Sirolimus may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store tablets at room temperature and away from light, excess heat, and moisture (not in the bathroom). Keep liquid medication in the refrigerator, away from light, closed tightly, and dispose of any unused medication one month after the bottle is opened. Do not freeze. If needed, you may store the bottles for up to 15 days at room temperature.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Rapamycin

Drug Interaction
Repaglinide Repaglinide The serum concentration of Repaglinide can be increased when it is combined with Sirolimus.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Sirolimus.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Sirolimus is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Sirolimus can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Sirolimus can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The risk or severity of adverse effects can be increased when Sirolimus is combined with Atorvastatin.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Sirolimus.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Sirolimus.
Cilostazol Cilostazol The metabolism of Sirolimus can be decreased when combined with Cilostazol.
Clopidogrel Clopidogrel The metabolism of Sirolimus can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Sirolimus can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The risk or severity of angioedema can be increased when Sirolimus is combined with Conjugated estrogens.
Fenofibrate Fenofibrate The metabolism of Sirolimus can be decreased when combined with Fenofibrate.
Methylergonovine Methylergonovine The metabolism of Sirolimus can be decreased when combined with Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Sirolimus.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Sirolimus is combined with Mycophenolic acid.
Paregoric Paregoric The serum concentration of Sirolimus can be increased when it is combined with Morphine.
Prednisone Prednisone The serum concentration of Sirolimus can be increased when it is combined with Prednisone.
Reserpine Reserpine The serum concentration of Sirolimus can be increased when it is combined with Reserpine.
Sumatriptan Sumatriptan The excretion of Sumatriptan can be decreased when combined with Sirolimus.
Tacrolimus Tacrolimus The risk or severity of adverse effects can be increased when Tacrolimus is combined with Sirolimus.
Triamcinolone Triamcinolone Triamcinolone may decrease the excretion rate of Sirolimus which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection The metabolism of Sirolimus can be decreased when combined with Doxycycline.
Fluconazole Injection Fluconazole Injection The serum concentration of Sirolimus can be increased when it is combined with Fluconazole.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Sirolimus.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirolimus.
Meperidine Injection Meperidine Injection The metabolism of Sirolimus can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The serum concentration of Sirolimus can be increased when it is combined with Methylprednisolone.
Metronidazole Injection Metronidazole Injection The metabolism of Sirolimus can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Sirolimus can be increased when it is combined with Morphine.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Sirolimus.
Cyclosporine Cyclosporine Sirolimus may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Sirolimus can be decreased when combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Sirolimus.
Torsemide Torsemide The excretion of Torasemide can be decreased when combined with Sirolimus.
Eprosartan Eprosartan The risk or severity of angioedema can be increased when Eprosartan is combined with Sirolimus.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Sirolimus is combined with Hydroxychloroquine.
Orlistat Orlistat The metabolism of Sirolimus can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Sirolimus can be increased when combined with Oxcarbazepine.
Telmisartan Telmisartan The risk or severity of angioedema can be increased when Sirolimus is combined with Telmisartan.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Sirolimus.
Zaleplon Zaleplon The metabolism of Sirolimus can be decreased when combined with Zaleplon.
Anakinra Anakinra The metabolism of Sirolimus can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Sirolimus.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Sirolimus.
Trimipramine Trimipramine The serum concentration of Trimipramine can be increased when it is combined with Sirolimus.
Etanercept Injection Etanercept Injection The metabolism of Sirolimus can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Sirolimus can be increased when combined with Modafinil.
Perindopril Perindopril The risk or severity of adverse effects can be increased when Perindopril is combined with Sirolimus.
Tenofovir Tenofovir The metabolism of Sirolimus can be decreased when combined with Tenofovir.
Dutasteride Dutasteride The metabolism of Sirolimus can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Sirolimus can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Sirolimus.
Eplerenone Eplerenone The metabolism of Sirolimus can be decreased when combined with Eplerenone.
Zonisamide Zonisamide Zonisamide may increase the immunosuppressive activities of Sirolimus.
Adalimumab Injection Adalimumab Injection The metabolism of Sirolimus can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Sirolimus can be decreased when combined with Aripiprazole.
Ezetimibe Ezetimibe The excretion of Ezetimibe can be decreased when combined with Sirolimus.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Sirolimus can be decreased when combined with Atazanavir.
Mefloquine Mefloquine The metabolism of Sirolimus can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Sirolimus can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The serum concentration of Sirolimus can be increased when it is combined with Vardenafil.
Aprepitant Aprepitant The metabolism of Sirolimus can be decreased when combined with Aprepitant.
Tegaserod Tegaserod The serum concentration of Sirolimus can be increased when it is combined with Tegaserod.
Tadalafil Tadalafil The metabolism of Sirolimus can be decreased when combined with Tadalafil.
Progesterone Progesterone The metabolism of Sirolimus can be increased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The metabolism of Sirolimus can be decreased when combined with Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Sirolimus can be increased when combined with Infliximab.
Rifaximin Rifaximin The metabolism of Sirolimus can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Sirolimus can be decreased when combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Sirolimus can be decreased when combined with Norethisterone.
Bosentan Bosentan The metabolism of Sirolimus can be increased when combined with Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Sirolimus can be decreased when combined with Erlotinib.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Sirolimus.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Sirolimus.
Voriconazole Voriconazole The serum concentration of Sirolimus can be increased when it is combined with Voriconazole.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirolimus.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirolimus.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be decreased when used in combination with Sirolimus.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Sirolimus.
Fentanyl Fentanyl The metabolism of Sirolimus can be decreased when combined with Fentanyl.
Pregabalin Pregabalin The risk or severity of angioedema can be increased when Pregabalin is combined with Sirolimus.
Deferasirox Deferasirox The metabolism of Sirolimus can be increased when combined with Deferasirox.
Tipranavir Tipranavir The serum concentration of Sirolimus can be increased when it is combined with Tipranavir.
Felbamate Felbamate The metabolism of Sirolimus can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Sirolimus.
Ranolazine Ranolazine The serum concentration of Sirolimus can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Sirolimus can be increased when combined with Abatacept.
Imatinib Imatinib The metabolism of Sirolimus can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The serum concentration of Sirolimus can be increased when it is combined with Sitagliptin.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Sirolimus.
Gefitinib Gefitinib The metabolism of Sirolimus can be decreased when combined with Gefitinib.
Paliperidone Paliperidone The serum concentration of Sirolimus can be increased when it is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Sirolimus.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Sirolimus.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sirolimus.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Sirolimus.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Sirolimus.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Sirolimus.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Sirolimus.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Sirolimus.
Posaconazole Posaconazole The metabolism of Sirolimus can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Sirolimus can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Sirolimus.
Darunavir Darunavir The serum concentration of Sirolimus can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Sirolimus.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Sirolimus is combined with Vorinostat.
Sorafenib Sorafenib The serum concentration of Sirolimus can be increased when it is combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sirolimus can be decreased when combined with Sunitinib.
Lapatinib Lapatinib The serum concentration of Sirolimus can be increased when it is combined with Lapatinib.
Dasatinib Dasatinib The metabolism of Sirolimus can be decreased when combined with Dasatinib.
Armodafinil Armodafinil The metabolism of Sirolimus can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Azacitidine.
Ivermectin Ivermectin The metabolism of Sirolimus can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Sirolimus can be decreased when combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Sirolimus.
Nilotinib Nilotinib The serum concentration of Sirolimus can be increased when it is combined with Nilotinib.
Toremifene Toremifene The serum concentration of Sirolimus can be increased when it is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Sirolimus can be increased when combined with Bexarotene.
Budesonide Budesonide The serum concentration of Sirolimus can be increased when it is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Sirolimus can be decreased when combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Decitabine.
Etravirine Etravirine The metabolism of Sirolimus can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Sirolimus can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Sirolimus can be decreased when combined with Desvenlafaxine.
Tretinoin Tretinoin The metabolism of Sirolimus can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Bendamustine.
Pilocarpine Pilocarpine The metabolism of Sirolimus can be decreased when combined with Pilocarpine.
Certolizumab Injection Certolizumab Injection The metabolism of Sirolimus can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Sirolimus can be decreased when combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Sirolimus can be decreased when combined with Irinotecan.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Sirolimus is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Sirolimus can be decreased when combined with Praziquantel.
Mitotane Mitotane The metabolism of Sirolimus can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Sirolimus.
Rufinamide Rufinamide The metabolism of Sirolimus can be increased when combined with Rufinamide.
Silodosin Silodosin The serum concentration of Sirolimus can be increased when it is combined with Silodosin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Sirolimus.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Sirolimus.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Sirolimus.
Milnacipran Milnacipran The metabolism of Sirolimus can be decreased when combined with Milnacipran.
Iloperidone Iloperidone The metabolism of Sirolimus can be decreased when combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Sirolimus.
Lacosamide Lacosamide The metabolism of Sirolimus can be decreased when combined with Lacosamide.
Everolimus Everolimus The metabolism of Sirolimus can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Sirolimus can be increased when it is combined with Tolvaptan.
Dronedarone Dronedarone The serum concentration of Sirolimus can be increased when it is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Pralatrexate.
Saxagliptin Saxagliptin The metabolism of Sirolimus can be decreased when combined with Saxagliptin.
Romidepsin Injection Romidepsin Injection The metabolism of Sirolimus can be decreased when combined with Romidepsin.
Topotecan Topotecan The metabolism of Sirolimus can be increased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Sirolimus can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Sirolimus can be decreased when combined with Pazopanib.
Pitavastatin Pitavastatin The excretion of Pitavastatin can be decreased when combined with Sirolimus.
Albendazole Albendazole The metabolism of Sirolimus can be decreased when combined with Albendazole.
Levonorgestrel Levonorgestrel The metabolism of Sirolimus can be decreased when combined with Levonorgestrel.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Sirolimus.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Sirolimus.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Sirolimus.
Tocilizumab Injection Tocilizumab Injection The metabolism of Sirolimus can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Sirolimus may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Sirolimus can be decreased when combined with Cabazitaxel.
Acetaminophen Injection Acetaminophen Injection The metabolism of Sirolimus can be increased when combined with Acetaminophen.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Sirolimus can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Sirolimus.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Belimumab.
Azilsartan Azilsartan The risk or severity of angioedema can be increased when Sirolimus is combined with Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Sirolimus.
Linagliptin Linagliptin The serum concentration of Sirolimus can be increased when it is combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Sirolimus can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The serum concentration of Sirolimus can be increased when it is combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Sirolimus can be increased when combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The metabolism of Sirolimus can be decreased when combined with Rivaroxaban.
Ticagrelor Ticagrelor The serum concentration of Sirolimus can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Sirolimus can be decreased when combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Sirolimus is combined with Ruxolitinib.
Vandetanib Vandetanib The serum concentration of Sirolimus can be increased when it is combined with Vandetanib.
Clobazam Clobazam The metabolism of Sirolimus can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Sirolimus can be increased when it is combined with Vemurafenib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Belatacept.
Ivacaftor Ivacaftor The serum concentration of Sirolimus can be increased when it is combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Sirolimus.
Axitinib Axitinib The metabolism of Sirolimus can be decreased when combined with Axitinib.
Crizotinib Crizotinib The metabolism of Sirolimus can be decreased when combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Sirolimus can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Sirolimus can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Sirolimus can be decreased when combined with Ambrisentan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Sirolimus.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Sirolimus.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Sirolimus.
Enzalutamide Enzalutamide The serum concentration of Sirolimus can be increased when it is combined with Enzalutamide.
Mirabegron Mirabegron The serum concentration of Sirolimus can be increased when it is combined with Mirabegron.
Regorafenib Regorafenib The serum concentration of Sirolimus can be increased when it is combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Sirolimus can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The serum concentration of Sirolimus can be increased when it is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Sirolimus is combined with Teriflunomide.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Sirolimus.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Sirolimus.
Tofacitinib Tofacitinib Sirolimus may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Sirolimus.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Sirolimus is combined with Dimethyl fumarate.
Ponatinib Ponatinib The serum concentration of Sirolimus can be increased when it is combined with Ponatinib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sirolimus.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Sirolimus can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Sirolimus can be decreased when combined with Apixaban.
Canagliflozin Canagliflozin The serum concentration of Sirolimus can be increased when it is combined with Canagliflozin.
Dabrafenib Dabrafenib The metabolism of Sirolimus can be increased when combined with Dabrafenib.
Trametinib Trametinib The metabolism of Sirolimus can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Sirolimus can be increased when it is combined with Dolutegravir.
Afatinib Afatinib The serum concentration of Sirolimus can be increased when it is combined with Afatinib.
Vortioxetine Vortioxetine The metabolism of Sirolimus can be decreased when combined with Vortioxetine.
Perampanel Perampanel The metabolism of Sirolimus can be increased when combined with Perampanel.
Ibrutinib Ibrutinib The metabolism of Sirolimus can be decreased when combined with Ibrutinib.
Lomitapide Lomitapide The serum concentration of Sirolimus can be increased when it is combined with Lomitapide.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Obinutuzumab.
Simeprevir Simeprevir The serum concentration of Sirolimus can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Sirolimus can be increased when it is combined with Sofosbuvir.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Sirolimus.
Apremilast Apremilast The metabolism of Sirolimus can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Sirolimus can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Sirolimus can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Sirolimus.
Eslicarbazepine Eslicarbazepine The metabolism of Sirolimus can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Idelalisib is combined with Sirolimus.
Testosterone Injection Testosterone Injection The metabolism of Sirolimus can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Sirolimus can be increased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Sirolimus.
Vorapaxar Vorapaxar The serum concentration of Sirolimus can be increased when it is combined with Vorapaxar.
Suvorexant Suvorexant The serum concentration of Sirolimus can be increased when it is combined with Suvorexant.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Sirolimus.
Edoxaban Edoxaban The serum concentration of Sirolimus can be increased when it is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Sirolimus can be decreased when combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Blinatumomab.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Sirolimus.
Tasimelteon Tasimelteon The metabolism of Sirolimus can be decreased when combined with Tasimelteon.
Lanreotide Injection Lanreotide Injection The metabolism of Sirolimus can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Sirolimus is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Sirolimus can be decreased when combined with Nintedanib.
Secukinumab Injection Secukinumab Injection The metabolism of Sirolimus can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Sirolimus can be decreased when combined with Risperidone.
Palbociclib Palbociclib The serum concentration of Sirolimus can be increased when it is combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Sirolimus.
Lenvatinib Lenvatinib The metabolism of Sirolimus can be increased when combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Panobinostat is combined with Sirolimus.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Sirolimus can be increased when it is combined with Haloperidol.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Sirolimus can be increased when it is combined with Isavuconazonium.
Flibanserin Flibanserin The serum concentration of Sirolimus can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Sirolimus can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone The serum concentration of Sirolimus can be increased when it is combined with Prednisolone.
Daclatasvir Daclatasvir The serum concentration of Sirolimus can be increased when it is combined with Daclatasvir.
Ziprasidone Injection Ziprasidone Injection The metabolism of Sirolimus can be decreased when combined with Ziprasidone.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Sirolimus.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Sirolimus.
Cobimetinib Cobimetinib The metabolism of Sirolimus can be decreased when combined with Cobimetinib.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Trabectedin.
Osimertinib Osimertinib The metabolism of Sirolimus can be increased when combined with Osimertinib.
Rifapentine Rifapentine The metabolism of Sirolimus can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Sirolimus can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Sirolimus can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The serum concentration of Sirolimus can be increased when it is combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Sirolimus.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Ixekizumab.
Venetoclax Venetoclax The serum concentration of Sirolimus can be increased when it is combined with Venetoclax.
Cobicistat Cobicistat The serum concentration of Sirolimus can be increased when it is combined with Cobicistat.
Selexipag Selexipag The serum concentration of Sirolimus can be increased when it is combined with Selexipag.
Rucaparib Rucaparib The serum concentration of Sirolimus can be increased when it is combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Sirolimus.
Ribociclib Ribociclib The metabolism of Sirolimus can be decreased when combined with Ribociclib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Sirolimus can be increased when combined with Brigatinib.
Deutetrabenazine Deutetrabenazine The metabolism of Sirolimus can be decreased when combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Sirolimus can be decreased when combined with Valbenazine.
Deflazacort Deflazacort The serum concentration of Sirolimus can be increased when it is combined with Deflazacort.
Safinamide Safinamide The metabolism of Sirolimus can be decreased when combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Ocrelizumab.
Sarilumab Injection Sarilumab Injection The metabolism of Sirolimus can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Sirolimus can be increased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Sirolimus can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Guselkumab.
Enasidenib Enasidenib The serum concentration of Sirolimus can be increased when it is combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Sirolimus can be increased when it is combined with Inotuzumab ozogamicin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Sirolimus can be increased when combined with Fosaprepitant.
Copanlisib Injection Copanlisib Injection The metabolism of Sirolimus can be decreased when combined with Copanlisib.
Abemaciclib Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Sirolimus.
Betrixaban Betrixaban The serum concentration of Sirolimus can be increased when it is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Sirolimus can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sirolimus.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Sirolimus.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Sirolimus.
Ertugliflozin Ertugliflozin The serum concentration of Sirolimus can be increased when it is combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Sirolimus can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The serum concentration of Sirolimus can be decreased when it is combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Sirolimus.
Fostamatinib Fostamatinib The metabolism of Sirolimus can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The serum concentration of Sirolimus can be increased when it is combined with Avatrombopag.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Baricitinib is combined with Sirolimus.
Eliglustat Eliglustat The serum concentration of Sirolimus can be increased when it is combined with Eliglustat.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Sirolimus.
Ivosidenib Ivosidenib The serum concentration of Sirolimus can be increased when it is combined with Ivosidenib.
Lusutrombopag Lusutrombopag The serum concentration of Sirolimus can be increased when it is combined with Lusutrombopag.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Sirolimus.
Doravirine Doravirine The metabolism of Sirolimus can be decreased when combined with Doravirine.
Cannabidiol Cannabidiol The metabolism of Sirolimus can be decreased when combined with Cannabidiol.
Dacomitinib Dacomitinib The serum concentration of Sirolimus can be increased when it is combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Sirolimus can be decreased when combined with Duvelisib.
Omadacycline Omadacycline The serum concentration of Sirolimus can be increased when it is combined with Omadacycline.
Sarecycline Sarecycline The serum concentration of Sirolimus can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Sirolimus can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Sirolimus can be increased when it is combined with Talazoparib.
Gilteritinib Gilteritinib The metabolism of Sirolimus can be decreased when combined with Gilteritinib.
Glasdegib Glasdegib The serum concentration of Sirolimus can be increased when it is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Sirolimus can be decreased when combined with Lorlatinib.
Larotrectinib Larotrectinib The serum concentration of Sirolimus can be increased when it is combined with Larotrectinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Sirolimus can be increased when combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Sirolimus can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Sirolimus can be decreased when combined with Prucalopride.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Sirolimus can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Sirolimus is combined with Siponimod.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Sirolimus.
Erdafitinib Erdafitinib The serum concentration of Sirolimus can be increased when it is combined with Erdafitinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Sirolimus can be increased when combined with Alpelisib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Sirolimus.
Darolutamide Darolutamide The serum concentration of Sirolimus can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Sirolimus can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The serum concentration of Entrectinib can be increased when it is combined with Sirolimus.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Sirolimus.
Pitolisant Pitolisant The serum concentration of Sirolimus can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Sirolimus.
Lefamulin Lefamulin The serum concentration of Sirolimus can be increased when it is combined with Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Sirolimus can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Sirolimus can be increased when combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Sirolimus can be increased when it is combined with Enfortumab vedotin.
Voxelotor Voxelotor The serum concentration of Sirolimus can be increased when it is combined with Voxelotor.
Lasmiditan Lasmiditan The serum concentration of Sirolimus can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Sirolimus can be increased when it is combined with Ubrogepant.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Sirolimus.
Cenobamate Cenobamate The serum concentration of Sirolimus can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Sirolimus is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Sirolimus.
Rimegepant Rimegepant The serum concentration of Sirolimus can be increased when it is combined with Rimegepant.
Tucatinib Tucatinib Tucatinib may decrease the excretion rate of Sirolimus which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Sirolimus.
Ripretinib Ripretinib The serum concentration of Sirolimus can be increased when it is combined with Ripretinib.
Capmatinib Capmatinib The serum concentration of Sirolimus can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Sirolimus.
Fostemsavir Fostemsavir The serum concentration of Sirolimus can be increased when it is combined with Fostemsavir.
Octreotide Octreotide The serum concentration of Sirolimus can be increased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Sirolimus.
Pralsetinib Pralsetinib The serum concentration of Sirolimus can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Sirolimus can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Sirolimus can be decreased when combined with Drospirenone.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Sirolimus can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Sirolimus.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Sirolimus.
Trazodone Trazodone The metabolism of Sirolimus can be decreased when combined with Trazodone.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Sirolimus is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Sirolimus.
Phenobarbital Phenobarbital The metabolism of Sirolimus can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Sirolimus.
Primidone Primidone The metabolism of Sirolimus can be increased when combined with Primidone.
Methsuximide Methsuximide Methsuximide may increase the immunosuppressive activities of Sirolimus.
Chlorpromazine Chlorpromazine The metabolism of Sirolimus can be increased when combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Sirolimus can be decreased when combined with Diazepam.
Lorazepam Lorazepam The metabolism of Sirolimus can be decreased when combined with Lorazepam.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Sirolimus.
Bromocriptine Bromocriptine The metabolism of Sirolimus can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Sirolimus can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Sirolimus can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Sirolimus is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The serum concentration of Ergoloid mesylate can be increased when it is combined with Sirolimus.
Tetracycline Tetracycline The metabolism of Sirolimus can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Sirolimus.
Prochlorperazine Prochlorperazine The metabolism of Sirolimus can be decreased when combined with Prochlorperazine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Sirolimus.
Dapsone Dapsone The metabolism of Sirolimus can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Sirolimus.
Oxycodone Oxycodone The metabolism of Sirolimus can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Sirolimus can be increased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Sirolimus can be decreased when combined with Oxybutynin.
Ibuprofen Ibuprofen The risk or severity of angioedema can be increased when Sirolimus is combined with Ibuprofen.
Orphenadrine Orphenadrine The metabolism of Sirolimus can be decreased when combined with Orphenadrine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Sirolimus is combined with Azathioprine.
Phentermine Phentermine The metabolism of Sirolimus can be decreased when combined with Phentermine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Sirolimus.
Hydrocortisone Hydrocortisone The serum concentration of Sirolimus can be increased when it is combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Sirolimus.
Doxorubicin Doxorubicin The metabolism of Sirolimus can be decreased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Sirolimus.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Sirolimus is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Sirolimus.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Sirolimus.
Clonidine Clonidine The metabolism of Sirolimus can be decreased when combined with Clonidine.
Hydralazine Hydralazine The metabolism of Sirolimus can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Sirolimus can be decreased when combined with Cimetidine.
Warfarin Warfarin The therapeutic efficacy of Warfarin can be increased when used in combination with Sirolimus.
Loperamide Loperamide Loperamide may increase the immunosuppressive activities of Sirolimus.
Daunorubicin Daunorubicin The metabolism of Sirolimus can be decreased when combined with Daunorubicin.
Griseofulvin Griseofulvin The metabolism of Sirolimus can be increased when combined with Griseofulvin.
Digoxin Digoxin The serum concentration of Digoxin can be increased when it is combined with Sirolimus.
Loxapine Loxapine The serum concentration of Sirolimus can be increased when it is combined with Loxapine.
Chloroquine Chloroquine The metabolism of Sirolimus can be decreased when combined with Chloroquine.
Quinine Quinine The serum concentration of Quinine can be increased when it is combined with Sirolimus.
Ethosuximide Ethosuximide Ethosuximide may increase the immunosuppressive activities of Sirolimus.
Calcitriol Calcitriol The metabolism of Sirolimus can be increased when combined with Calcitriol.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Sirolimus.
Sulfinpyrazone Sulfinpyrazone The metabolism of Sirolimus can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Sirolimus.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Sirolimus.
Secobarbital Secobarbital The metabolism of Sirolimus can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Sirolimus can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Sirolimus can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Sirolimus can be decreased when combined with Imipramine.
Probenecid Probenecid The metabolism of Sirolimus can be increased when combined with Probenecid.
Quinidine Quinidine The serum concentration of Quinidine can be increased when it is combined with Sirolimus.
Isoniazid Isoniazid The metabolism of Sirolimus can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Sirolimus can be increased when combined with Rifampicin.
Disopyramide Disopyramide Sirolimus may increase the QTc-prolonging activities of Disopyramide.
Valproic Acid Valproic Acid The metabolism of Sirolimus can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Sirolimus can be increased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Sirolimus.
Levothyroxine Levothyroxine The serum concentration of Levothyroxine can be decreased when it is combined with Sirolimus.
Liothyronine Liothyronine The excretion of Liothyronine can be decreased when combined with Sirolimus.
Methimazole Methimazole The metabolism of Sirolimus can be decreased when combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Sirolimus.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Sirolimus.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Sirolimus.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Sirolimus.
Dextromethorphan Dextromethorphan The metabolism of Sirolimus can be decreased when combined with Dextromethorphan.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Sirolimus.
Niacin Niacin The metabolism of Sirolimus can be decreased when combined with Niacin.
Chlorpheniramine Chlorpheniramine The metabolism of Sirolimus can be decreased when combined with Chlorpheniramine.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Sirolimus.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Sirolimus.
Danazol Danazol The metabolism of Sirolimus can be decreased when combined with Danazol.
Disulfiram Disulfiram The metabolism of Sirolimus can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Sirolimus can be decreased when combined with Propranolol.
Nortriptyline Nortriptyline The serum concentration of Nortriptyline can be increased when it is combined with Sirolimus.
Amphotericin B Injection Amphotericin B Injection The metabolism of Sirolimus can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Sirolimus is combined with Mercaptopurine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Sirolimus.
Clomiphene Clomiphene The serum concentration of Sirolimus can be increased when it is combined with Clomifene.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sirolimus.
Colchicine Colchicine The metabolism of Sirolimus can be increased when combined with Colchicine.
Cephalexin Cephalexin The metabolism of Sirolimus can be decreased when combined with Cephalexin.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Sirolimus.
Acetazolamide Acetazolamide The metabolism of Sirolimus can be decreased when combined with Acetazolamide.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Sirolimus.
Ketoconazole Ketoconazole The serum concentration of the active metabolites of Sirolimus can be increased when Sirolimus is used in combination with Ketoconazole.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Sirolimus can be decreased when combined with Vincristine.
Captopril Captopril The risk or severity of adverse effects can be increased when Captopril is combined with Sirolimus.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Sirolimus.
Vinblastine Vinblastine The metabolism of Sirolimus can be increased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Sirolimus can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The metabolism of Hydroxyzine can be decreased when combined with Sirolimus.
Aspirin Aspirin The risk or severity of angioedema can be increased when Acetylsalicylic acid is combined with Sirolimus.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Sirolimus.
Alprazolam Alprazolam The serum concentration of Alprazolam can be increased when it is combined with Sirolimus.
Triazolam Triazolam The serum concentration of Triazolam can be increased when it is combined with Sirolimus.
Diltiazem Diltiazem Diltiazem may increase the immunosuppressive activities of Sirolimus.
Nifedipine Nifedipine Nifedipine may increase the immunosuppressive activities of Sirolimus.
Verapamil Verapamil The serum concentration of Sirolimus can be increased when it is combined with Verapamil.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Sirolimus.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Sirolimus.
Etoposide Etoposide The metabolism of Sirolimus can be increased when combined with Etoposide.
Glyburide Glyburide The metabolism of Sirolimus can be decreased when combined with Glyburide.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Sirolimus.
Dicloxacillin Dicloxacillin The metabolism of Sirolimus can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Sirolimus can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Sirolimus.
Pentamidine Injection Pentamidine Injection The metabolism of Sirolimus can be decreased when combined with Pentamidine.
Pimozide Pimozide The metabolism of Sirolimus can be decreased when combined with Pimozide.
Enalapril Enalapril The risk or severity of adverse effects can be increased when Enalapril is combined with Sirolimus.
Amiodarone Amiodarone Amiodarone may increase the immunosuppressive activities of Sirolimus.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Sirolimus.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Sirolimus.
Ciprofloxacin Ciprofloxacin The metabolism of Sirolimus can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The risk or severity of angioedema can be increased when Diclofenac is combined with Sirolimus.
Nimodipine Nimodipine Nimodipine may increase the immunosuppressive activities of Sirolimus.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Sirolimus.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Sirolimus is combined with Clozapine.
Estazolam Estazolam The serum concentration of Estazolam can be increased when it is combined with Sirolimus.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Sirolimus is combined with Idarubicin.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Sirolimus.
Clarithromycin Clarithromycin The metabolism of Sirolimus can be decreased when combined with Clarithromycin.
Benazepril Benazepril The risk or severity of adverse effects can be increased when Benazepril is combined with Sirolimus.
Felodipine Felodipine Felodipine may increase the immunosuppressive activities of Sirolimus.
Fosinopril Fosinopril The risk or severity of adverse effects can be increased when Fosinopril is combined with Sirolimus.
Pravastatin Pravastatin The serum concentration of Pravastatin can be increased when it is combined with Sirolimus.
Quinapril Quinapril The risk or severity of adverse effects can be increased when Sirolimus is combined with Quinapril.
Ramipril Ramipril The risk or severity of adverse effects can be increased when Ramipril is combined with Sirolimus.
Simvastatin Simvastatin The metabolism of Sirolimus can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Amlodipine may increase the immunosuppressive activities of Sirolimus.
Teniposide Injection Teniposide Injection The metabolism of Sirolimus can be decreased when combined with Teniposide.
Itraconazole Itraconazole The serum concentration of the active metabolites of Sirolimus can be increased when Sirolimus is used in combination with Itraconazole.
Lisinopril Lisinopril The risk or severity of adverse effects can be increased when Lisinopril is combined with Sirolimus.
Rifabutin Rifabutin The metabolism of Sirolimus can be increased when combined with Rifabutin.
Bisoprolol Bisoprolol The serum concentration of Sirolimus can be increased when it is combined with Bisoprolol.
Doxazosin Doxazosin The metabolism of Sirolimus can be decreased when combined with Doxazosin.
Isradipine Isradipine Isradipine may increase the immunosuppressive activities of Sirolimus.
Omeprazole Omeprazole The metabolism of Sirolimus can be increased when combined with Omeprazole.
Cisapride Cisapride The serum concentration of Cisapride can be increased when it is combined with Sirolimus.
Fluvastatin Fluvastatin The metabolism of Sirolimus can be decreased when combined with Fluvastatin.
Famciclovir Famciclovir The metabolism of Sirolimus can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Sirolimus can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Sirolimus can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine Sirolimus may increase the immunosuppressive activities of Lamotrigine.
Losartan Losartan The metabolism of Sirolimus can be decreased when combined with Losartan.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sirolimus.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Sirolimus is combined with Carboplatin.
Moexipril Moexipril The risk or severity of adverse effects can be increased when Moexipril is combined with Sirolimus.
Lansoprazole Lansoprazole The metabolism of Sirolimus can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Sirolimus can be increased when combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Sirolimus.
Nicardipine Nicardipine Nicardipine may increase the immunosuppressive activities of Sirolimus.
Ticlopidine Ticlopidine The metabolism of Sirolimus can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Sirolimus can be decreased when combined with Saquinavir.
Metformin Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Sirolimus.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Sirolimus.
Nisoldipine Nisoldipine Nisoldipine may increase the immunosuppressive activities of Sirolimus.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Sirolimus.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Sirolimus.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sirolimus.
Indinavir Indinavir The metabolism of Sirolimus can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Sirolimus can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Sirolimus can be decreased when combined with Docetaxel.
Zafirlukast Zafirlukast The metabolism of Sirolimus can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Sirolimus can be decreased when combined with Mirtazapine.
Trandolapril Trandolapril The risk or severity of adverse effects can be increased when Trandolapril is combined with Sirolimus.
Topiramate Topiramate The metabolism of Sirolimus can be increased when combined with Topiramate.
Valsartan Valsartan The risk or severity of angioedema can be increased when Valsartan is combined with Sirolimus.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Sirolimus.
Nelfinavir Nelfinavir The metabolism of Sirolimus can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine The serum concentration of Sirolimus can be increased when it is combined with Fexofenadine.
Azithromycin Azithromycin The metabolism of Sirolimus can be decreased when combined with Azithromycin.
Carvedilol Carvedilol Carvedilol may increase the immunosuppressive activities of Sirolimus.
Flutamide Flutamide The metabolism of Sirolimus can be decreased when combined with Flutamide.
Bicalutamide Bicalutamide The metabolism of Sirolimus can be decreased when combined with Bicalutamide.
Propafenone Propafenone The serum concentration of Sirolimus can be increased when it is combined with Propafenone.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Sirolimus.
Irbesartan Irbesartan The metabolism of Sirolimus can be decreased when combined with Irbesartan.
Finasteride Finasteride The metabolism of Sirolimus can be decreased when combined with Finasteride.
Quetiapine Quetiapine The metabolism of Sirolimus can be decreased when combined with Quetiapine.
Paroxetine Paroxetine The metabolism of Sirolimus can be decreased when combined with Paroxetine.
Citalopram Citalopram The metabolism of Sirolimus can be decreased when combined with Citalopram.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Sirolimus is combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Sirolimus can be increased when combined with Efavirenz.
Sildenafil Sildenafil The serum concentration of Sirolimus can be increased when it is combined with Sildenafil.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Sirolimus.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Sirolimus.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Sirolimus.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Sirolimus is combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Sirolimus can be decreased when combined with Nateglinide.
Rabeprazole Rabeprazole The metabolism of Sirolimus can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Sirolimus can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists